Clinical Aggressiveness and Long-Term Outcome in Patients with Papillary Thyroid Cancer and Circulating Anti-Thyroglobulin Autoantibodies-Reference-Cited by-同舟云学术

Clinical Aggressiveness and Long-Term Outcome in Patients with Papillary Thyroid Cancer and Circulating Anti-Thyroglobulin Autoantibodies

Published:2014-07 Issue:7 Volume:24 Page:1139-1145
ISSN:1050-7256
Container-title:Thyroid
language:en
Short-container-title:Thyroid

Author:

Durante Cosimo¹,Tognini Sara²,Montesano Teresa¹,Orlandi Fabio³,Torlontano Massimo⁴,Puxeddu Efisio⁵,Attard Marco⁶,Costante Giuseppe⁷⁸,Tumino Salvatore⁹,Meringolo Domenico¹⁰,Bruno Rocco¹¹,Trulli Fabiana¹,Toteda Maria¹,Redler Adriano¹²,Ronga Giuseppe¹,Filetti Sebastiano¹,Monzani Fabio²,

Affiliation:

1. Department of Internal Medicine and Medical Specialties, University of Rome Sapienza, Rome, Italy.

2. Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.

3. Department of Clinical and Biological Sciences, University of Turin, Turin, Italy.

4. Endocrinology Unit, IRCCS, Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy.

5. Department of Internal Medicine, University of Perugia, Perugia, Italy.

6. Endocrinology Unit, Azienda Ospedaliera Ospedali Riuniti Villa Sofia-Cervello, Palermo, Italy.

7. Department of Health Sciences, University of Catanzaro, Catanzaro, Italy.

8. Department of Internal Medicine, Institute Jules Bordet, Bruxelles, Belgium.

9. Department of Medical and Pediatric Sciences, University of Catania, Catania, Italy.

10. Endocrinology Unit, Bentivoglio Hospital, Bologna, Italy.

11. Endocrinology Unit, Tinchi-Pisticci Hospital, Matera, Italy.

12. Department of Surgical Sciences, University of Rome Sapienza, Rome, Italy.

Publisher

Mary Ann Liebert Inc

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://www.liebertpub.com/doi/pdf/10.1089/thy.2013.0698

Reference29 articles.

1. Cancer Statistics, 2006

2. Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer

3. Clinical Utility of Thyroglobulin Antibody (TgAb) Measurements for Patients with Differentiated Thyroid Cancers (DTC)

4. Clinical significance of elevated level of serum antithyroglobulin antibody in patients with differentiated thyroid cancer after thyroid ablation

Cited by 78 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diagnostic performance of 2-[18F]FDG PET/CT in recurrent differentiated thyroid cancer and elevated antithyroglobulin antibodies: an updated systematic review and bivariate meta-analysis;Endocrine;2024-09-09

2. Valor de la 18F-FDG-PET/CT en la estadificación inicial de pacientes con cáncer de tiroides de moderado/alto riesgo con subtipos histológicos agresivos;Investigación Clínica;2024-05-22

3. Influence of Thyroglobulin Autoantibodies on Thyroglobulin Levels Measured by Different Methodologies: IMA, LC-MS/MS, and RIA;The Journal of Clinical Endocrinology & Metabolism;2024-04-30

4. Thyroglobulin Antibodies and Tumor Epitope-Specific Cellular Immunity in Papillary Thyroid Cancer;Hormone and Metabolic Research;2024-04-15

5. The effect of positive thyroglobulin antibodies on the prognosis and treatment response in patients with papillary thyroid carcinoma;Heliyon;2024-02